Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
出版年份 2023 全文链接
标题
Uncoupling hepatic insulin resistance – hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-06-15
DOI
10.3389/fendo.2023.1193373
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist
- (2022) Brett E. Phillips et al. Cardiovascular Diabetology
- Health disparities in chronic liver disease
- (2022) Ani Kardashian et al. HEPATOLOGY
- Short-term overnutrition induces white adipose tissue insulin resistance through sn-1,2-diacylglycerol – PKCε – insulin receptorT1160 phosphorylation
- (2021) Kun Lyu et al. JCI Insight
- Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
- (2021) Leigh Goedeke et al. Molecular Metabolism
- IL-6 Receptor Blockade Increases Circulating Adiponectin Levels in People with Obesity: An Explanatory Analysis
- (2021) Stephan Wueest et al. Metabolites
- Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide
- (2021) Michele Schiavon et al. DIABETES OBESITY & METABOLISM
- Liver-targeting drugs and their effect on blood glucose and hepatic lipids
- (2021) Amalia Gastaldelli et al. DIABETOLOGIA
- Associations among adipose tissue immunology, inflammation and exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease
- (2021) Anja Fuchs et al. GASTROENTEROLOGY
- Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease
- (2021) Zoi Michailidou et al. Journal of Innate Immunity
- Enhanced Palmitate-Induced Interleukin-8 Formation in Human Macrophages by Insulin or Prostaglandin E2
- (2021) Janin Henkel et al. Biomedicines
- Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
- (2021) Sara Della Torre Cells
- CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
- (2021) Vanessa Castelli et al. Cells
- Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity
- (2020) Ada Weinstock et al. CIRCULATION RESEARCH
- Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
- (2020) Manjunath Krishnappa et al. Cardiovascular Diabetology
- Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes
- (2020) Christin Krause et al. DIABETOLOGIA
- Metabolic liver disease in diabetes – From mechanisms to clinical trials
- (2020) Bedair Dewidar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
- (2020) Carol Wysham et al. POSTGRADUATE MEDICINE
- A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance
- (2020) Kun Lyu et al. Cell Metabolism
- Cellular and Molecular Mechanisms of Metformin Action
- (2020) Traci E LaMoia et al. ENDOCRINE REVIEWS
- Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
- (2020) Laurie L. Baggio et al. Molecular Metabolism
- Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
- (2020) Sara Della Torre Frontiers in Endocrinology
- Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
- (2020) Kalliopi Pafili et al. Molecular Metabolism
- Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism
- (2019) Takayoshi Sasako et al. Nature Communications
- The effects of metformin on insulin resistance in overweight or obese children and adolescents
- (2019) Juan Sun et al. MEDICINE
- Chemokine Receptor Redundancy and Specificity Are Context Dependent
- (2019) Douglas P. Dyer et al. IMMUNITY
- Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism
- (2019) Kayleigh M Beaudry et al. Applied Physiology Nutrition and Metabolism
- Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading
- (2019) Raid B. Nisr et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial
- (2019) Yanislava Karusheva et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
- (2019) Sabine Kahl et al. DIABETES CARE
- Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
- (2019) Helena W. Rodbard et al. DIABETES CARE
- Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
- (2019) Menso J. Westerouen Van Meeteren et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
- (2019) Laura I. Hudish et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Ceramides in Insulin Resistance
- (2019) Emilia Sokolowska et al. Frontiers in Endocrinology
- Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index
- (2019) Maki Tobari et al. Gut and Liver
- The integrative biology of type 2 diabetes
- (2019) Michael Roden et al. NATURE
- Effect of a Dual PPAR α/γ agonist on Insulin Sensitivity in Patients of Type 2 Diabetes with Hypertriglyceridemia- Randomized double-blind placebo-controlled trial
- (2019) Nimisha Jain et al. Scientific Reports
- Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
- (2018) Maria Apostolopoulou et al. DIABETES CARE
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
- (2018) Midori Honma et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2018) Luis E. Simental-Mendía et al. PHARMACOLOGICAL RESEARCH
- Interorgan Metabolic Crosstalk in Human Insulin Resistance
- (2018) Sofiya Gancheva et al. PHYSIOLOGICAL REVIEWS
- Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers
- (2018) Marie Cullberg et al. Drugs in research & development
- ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
- (2018) Ju Youn Kim et al. CELL
- Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1
- (2018) Hui Yan et al. DIABETES
- Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
- (2018) Kenneth Cusi et al. DIABETES OBESITY & METABOLISM
- Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance
- (2017) Elisa Álvarez Hernández et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
- (2017) Allison B. Goldfine et al. JOURNAL OF CLINICAL INVESTIGATION
- Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
- (2017) Yong-ho Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Inflammation, metaflammation and immunometabolic disorders
- (2017) Gökhan S. Hotamisligil NATURE
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
- (2017) Ruth C. R. Meex et al. Nature Reviews Endocrinology
- Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
- (2017) Max C. Petersen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production
- (2016) Paul M. Titchenell et al. Cell Metabolism
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- The role of macrophages in obesity-driven chronic liver disease
- (2016) Lindsey Devisscher et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance
- (2016) Peter Bond Journal of the International Society of Sports Nutrition
- Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
- (2016) Paul M O'Byrne et al. Lancet Respiratory Medicine
- Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Giulia Ferrannini et al. DIABETES CARE
- Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study
- (2015) J. Miyagawa et al. DIABETES OBESITY & METABOLISM
- Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
- (2015) Hideaki Jinnouchi et al. Journal of Diabetes Research
- Sex-Specific Differences in Lipid and Glucose Metabolism
- (2015) Oleg Varlamov et al. Frontiers in Endocrinology
- CXC Chemokines Function as a Rheostat for Hepatocyte Proliferation and Liver Regeneration
- (2015) Gregory C. Wilson et al. PLoS One
- Tuberous Sclerosis Complex 1–Mechanistic Target of Rapamycin Complex 1 Signaling Determines Brown-to-White Adipocyte Phenotypic Switch
- (2014) Xinxin Xiang et al. DIABETES
- Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation
- (2014) Gordon I. Smith et al. DIABETES
- The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects
- (2014) Rémy Hanf et al. Diabetes & Vascular Disease Research
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- Regulation of mTORC1 by amino acids
- (2014) Liron Bar-Peled et al. TRENDS IN CELL BIOLOGY
- Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance
- (2013) Byung-Cheol Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)
- (2013) Bo Ahrén et al. DIABETES CARE
- Dual Peroxisome Proliferator-Activated Receptor / Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
- (2013) B. Cariou et al. DIABETES CARE
- Anti-inflammatory cytokines and risk of type 2 diabetes
- (2013) C. Herder et al. DIABETES OBESITY & METABOLISM
- Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
- (2012) Stephanie Coulon et al. CYTOKINE
- Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults
- (2012) P. Wurtz et al. DIABETES CARE
- Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
- (2012) Saswata Talukdar et al. NATURE MEDICINE
- Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase
- (2012) J. L. Owen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammatory Mechanisms in Obesity
- (2011) Margaret F. Gregor et al. Annual Review of Immunology
- Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1c
- (2011) Min Wan et al. Cell Metabolism
- Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
- (2011) Jessica L. Yecies et al. Cell Metabolism
- FoxO Feedback Control of Basal IRS-2 Expression in Pancreatic β-Cells Is Distinct From That in Hepatocytes
- (2011) Shin Tsunekawa et al. DIABETES
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
- (2011) Olivier Bezy et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammatory links between obesity and metabolic disease
- (2011) Carey N. Lumeng et al. JOURNAL OF CLINICAL INVESTIGATION
- Unknown
- (2011) Thomas Wascher et al. MOLECULAR MEDICINE
- Tuberous Sclerosis Complex-1 Deficiency Attenuates Diet-Induced Hepatic Lipid Accumulation
- (2011) Heidi L. Kenerson et al. PLoS One
- Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
- (2011) N. Kumashiro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
- (2011) Esther Phielix et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Endoplasmic reticulum stress in liver disease
- (2010) Harmeet Malhi et al. JOURNAL OF HEPATOLOGY
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
- (2010) Shijie Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin Resistance
- (2009) Carine Chavey et al. Cell Metabolism
- CCR2 promotes hepatic fibrosis in mice
- (2009) Ekihiro Seki et al. HEPATOLOGY
- The Effect of Branched Chain Amino Acids on Skeletal Muscle Mitochondrial Function in Young and Elderly Adults
- (2009) Laura L. Tatpati et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibitory effect of IL-8 on insulin action in human adipocytes via MAP kinase pathway
- (2009) Chikaaki Kobashi et al. Journal of Inflammation-London
- Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus
- (2008) Shelley R. Salpeter et al. AMERICAN JOURNAL OF MEDICINE
- Selective versus Total Insulin Resistance: A Pathogenic Paradox
- (2008) Michael S. Brown et al. Cell Metabolism
- Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss
- (2008) M. F. Gregor et al. DIABETES
- Endoplasmic Reticulum Stress Markers Are Associated with Obesity in Nondiabetic Subjects
- (2008) Neeraj K. Sharma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
- (2008) G. Sabio et al. SCIENCE
- Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
- (2007) Puneet Puri et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started